Forskel mellem versioner af "Oxford–AstraZeneca COVID-19 vaccine"

Ingen ændring i størrelsen ,  for 2 måneder siden
m
(Oversætter afsnit fra enwiki + reflist)
Det [[Europæiske Lægemiddelagentur]] (''European Medicines Agency'' eller blot EMA) påbegyndte en undersøgelse af vaccinen 12. januar 2021, og udtalte i en pressemeddelelse at agenturet kunne udsende en godkendelse 29. januar, hvorefter [[EU-Kommissionen]] kunne beslutte sig for betinget markedsføringsautorisering indenfor få dage.<ref name="EMA application">{{cite news|date=12 January 2021|title=EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca|website=[[Europæiske Lægemiddelagentur]] (EMA)|url=https://www.ema.europa.eu/en/news/ema-receives-application-conditional-marketing-authorisation-covid-19-vaccine-astrazeneca|access-date=12 January 2021}}</ref> 29. januar 2021 anberfalede EMA at give en betinget markedsføringsautorisering for AZD1222 for personer på 18 år og op,<ref name="COVID-19 Vaccine AstraZeneca EPAR" /><ref name="EMA recommendation">{{cite press release | title=EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU | website=[[Europæiske Lægemiddelagentur]] (EMA) | date=29 January 2021 | url=https://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-astrazeneca-authorisation-eu | access-date=29 January 2021}}</ref> og anbefalingen blev accepteret af EU-Kommissionen samme dag.<ref name="EU PR 20210129" /><ref name="EU UR info">{{cite web | title=COVID-19 Vaccine AstraZeneca | website=Union Register of medicinal products | url=https://ec.europa.eu/health/documents/community-register/html/h1529.htm | access-date=18 February 2021}}</ref> Den ungarske regulator havde allerede inden EU-godkendelsesproceduren valgt at godkende vaccinen til brug i Ungarn.<ref name="hungary">{{cite web|url=https://hungarytoday.hu/oxford-astrazeneca-vaccine-hungary/|title=Everything You Need to Know About the Oxford-AstraZeneca Vaccine|date=23 January 2021}}</ref>
 
30. januar 2021 godkendte [[Vietnams sundhedsministerium]] AstraZeneca-vaccinen til anvendelse, og den blev dermed den første godkendte vaccine i [[Vietnam]],<ref>{{cite web|last=Nikkei staff writers|title=Coronavirus: Week of Jan.&nbsp;24 to Jan.&nbsp;30, Vietnam approves AstraZeneca vaccine|url=https://asia.nikkei.com/Spotlight/Coronavirus/Coronavirus-Free-to-read/Coronavirus-Week-of-Jan.-24-to-Jan.-30-Vietnam-approves-AstraZeneca-vaccine|website=Nikkei Asia}}</ref> ligesom den 10. februar 2021 blev den første godkendte vaccine i [[Sydkorea]].<ref>{{cite news | vauthors = Kim HJ |date=10 February 2021|title=S. Korea approves AstraZeneca's COVID-19 vaccine for all adults|url=https://en.yna.co.kr/view/AEN20210210006351320|access-date=10 February 2021|publisher=Yonhap News Agency}}</ref><ref>{{cite news | vauthors = Maresca T |date=10 February 2021|title=South Korea approves AstraZeneca COVID-19 vaccine|url=https://www.upi.com/Top_News/World-News/2021/02/10/South-Korea-approves-AstraZeneca-COVID-19-vaccine/4231612945438/|access-date=10 February 2021|publisher=United Press International}}</ref> Vaccinen er derudover blevet godkendt til nødanvendelse i en andre række andre ikke-EU-lande, heriblandt Argentina,<ref>{{cite news | vauthors = Laing A |title=Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine -AstraZeneca |url=https://www.reuters.com/article/us-health-coronavirus-argentina-astrazen/argentine-regulator-approves-astrazeneca-oxford-covid-19-vaccine-astrazeneca-idUSKBN29421P |work=Reuters |date=30 December 2020 }}</ref> Bangladesh,<ref>{{cite news |title=Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use |url=https://www.thedailystar.net/frontpage/news/oxford-university-astrazeneca-vaccine-bangladesh-okays-it-emergency-use-2022381 |access-date=7 January 2021 |work=The Daily Star |date=4 January 2021 }}</ref> Brasilien,<ref>{{cite web | vauthors = Sabóia G, Mazieiro G, de Andrade H, Adorno L |title=Anvisa aprova uso emergencial das vacinas CoronaVac e AstraZeneca no Brasil|trans-title=Anvisa approves emergency use of the CoronaVac and AstraZeneca vaccines in Brazil|url=https://noticias.uol.com.br/saude/ultimas-noticias/redacao/2021/01/17/anvisa-aprova-pedido-de-vacina-do-butantan-e-da-fiocruz.htm|work=[[Universo Online|UOL]]|language=pt|date=17 January 2021|access-date=17 January 2021}}</ref> Den Dominikanske Republik,<ref name="la-republica-dominicana">{{cite news |title=La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19 |trans-title=The Dominican Republic approves the AstraZeneca vaccine against covid-19 |url=https://www.efe.com/efe/america/sociedad/la-republica-dominicana-aprueba-vacuna-de-astrazeneca-contra-covid-19/20000013-4431079 |work=Agencia EFE |date=31 December 2020 |language=es}}</ref> El Salvador,<ref>{{cite news |title=El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine |url=https://www.reuters.com/article/us-health-coronavirus-el-salvador-vaccin/el-salvador-greenlights-astrazeneca-oxford-university-covid-19-vaccine-idINKBN2942HQ |work=Reuters |date=30 December 2020 }}</ref> Indien,<ref>{{cite news | vauthors = Gaurav K |title=Govt's expert panel approves AstraZeneca/Oxford Covid-19 vaccine for emergency use |url=https://www.hindustantimes.com/india-news/india-s-drug-regulator-approves-astrazeneca-oxford-vaccine-sources/story-qtnJQQTBI5vR6QGrXdoBzN.html |work=Hindustan Times |date=1 January 2021 }}</ref><ref>{{cite news | vauthors = Prusty N, Jamkhandikar S |title=India drug regulator approves AstraZeneca COVID vaccine, country's first – sources |url=https://in.reuters.com/article/health-coronavirus-india-vaccine-idINKBN296290 |work=Reuters |date=1 January 2021 }}</ref> Malaysia,<ref>{{cite web|url=https://codeblue.galencentre.org/2021/03/02/malaysias-npra-approves-astrazeneca-sinovac-covid-19-vaccines/|title=Malaysia's NPRA Approves AstraZeneca, Sinovac Covid-19 Vaccines|publisher=CodeBlue|date=2 March 2021|access-date=2 March 2021}}</ref> Mexico,<ref>{{cite news | author = Comisión Federal para la Protección contra Riesgos Sanitarios |title=Autorización Para Uso De Emergencia A Vacuna AstraZeneca COVID-19 |url=https://www.gob.mx/cofepris/articulos/autorizacion-para-uso-de-emergencia-a-vacuna-astrazeneca-covid-19 | trans-title=Authorization For Emergency Use Of AstraZeneca Covid-19 Vaccine |access-date=7 January 2021 |work=gob.mx |language=es}}</ref> Nepal,<ref>{{cite news | title=Nepal approves AstraZeneca COVID vaccine for emergency use – government statement |url=https://www.reuters.com/article/health-coronavirus-nepal/nepal-approves-astrazeneca-covid-vaccine-for-emergency-use-government-statement-idUSKBN29K140 |work=Reuters |date=15 January 2021 }}</ref> Pakistan,<ref>{{cite news| vauthors = Shahzad A |date=16 January 2021|title=Pakistan approves AstraZeneca COVID-19 vaccine for emergency use|work=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-pakistan-astrazene-idUKKBN29L0DO|access-date=16 January 2021}}</ref> Filippinerne,<ref name="Reuters">{{cite news |date=28 January 2021 |title=Philippine regulator approves emergency use of AstraZeneca vaccine |work=Reuters |url=https://www.reuters.com/article/us-health-coronavirus-philippines-vaccin-idUSKBN29X0CY |access-date=28 January 2021}}</ref> Sri Lanka,<ref name="apnews.com">{{cite web|date=22 January 2021|title=Sri Lanka approves vaccine amid warnings of virus spread|url=https://apnews.com/article/sri-lanka-coronavirus-pandemic-340488c48ab372050825e70e057dd294|access-date=22 January 2021|website=AP NEWS}}</ref> Taiwan,<ref>{{cite web|title=Taiwan grants emergency authorisation for AstraZeneca COVID-19 vaccine|url=https://www.msn.com/en-xl/news/newsworld/taiwan-grants-emergency-authorisation-for-astrazeneca-covid-19-vaccine/ar-BB1dQvEk|access-date=22 February 2021|publisher=MSN}}</ref> Australien<ref name="ChAdOx1-S AU PI" /><ref name="AU TGA decision" /> og Canada.<ref>{{cite web|last=Canada|first=Health|title=COVID-19 vaccines and treatments portal: AstraZeneca COVID-19 Vaccine (ChAdOx1-S [recombinant])|url=https://covid-vaccine.canada.ca/astrazeneca-covid-19-vaccine/product-details|access-date=26 February 2021|website=Health Canada}}</ref>
 
10. februar 2021 udsendte [[Verdenssundhedsorganisationen]] (WHO) en midlertidig vejledning og anbefalede AstraZeneca-vaccinen for alle voksne, efter organisationens [[Strategic Advisory Group of Experts]] også havde vurderet tilfælde hvor der var flere varianter til stede, og vurderede at der ikke var nogen grund til ikke at anbefale den.<ref name="RTÉ-20210210">{{cite news|title=AstraZeneca-Oxford vaccine can be used for people aged over 65 – WHO|date=10 February 2021|url=https://www.rte.ie/news/coronavirus/2021/0210/1196328-coronavirus-astrazeneca-vaccine-who/|access-date=12 February 2021|publisher=[[RTÉ News and Current Affairs]]}}</ref>